(Q46914955)

26 December 2017

title

Effect of high-dose methylprednisolone treatment on CCR5 expression on blood cells in MS exacerbation (English)

1 reference

26 December 2017

1 reference

Elovaara I

1

1 reference

26 December 2017

Kuusisto H

2

1 reference

26 December 2017

Paalavuo R

3

1 reference

26 December 2017

Särkijärvi S

4

1 reference

26 December 2017

Lehtimäki T

5

1 reference

26 December 2017

Huhtala H

6

1 reference

26 December 2017

Vilpo J

7

1 reference

26 December 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

26 December 2017

Acta Neurologica Scandinavica

published in

1 reference

26 December 2017

volume

113

1 reference

26 December 2017

issue

3

1 reference

26 December 2017

page(s)

163-166

1 reference

26 December 2017

Immunopathology of multiple sclerosis: report on an international meeting held at the Institute of Neurology of the University of Vienna.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00566.X

Corticosteroids treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00566.X

Clinical impact of intravenous methylprednisolone in attacks of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00566.X

Chemokines: multiple levels of leukocyte migration control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00566.X

Chemokines and leukocyte traffic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00566.X

Chemokine receptors in inflammation: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00566.X

CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00566.X

Differential intracellular expression of CCR5 and chemokines in multiple sclerosis subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00566.X

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00566.X

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00566.X

Treatment with methylprednisolone in relapses of multiple sclerosis patients: immunological evidence of immediate and short-term but not long-lasting effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00566.X

CCR5 is characteristic of Th1 lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00566.X

10.1111/J.1600-0404.2005.00566.X

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017